Trade Amgen ^AMGN

Forget Nvidia. Johnson & Johnson and 2 Other AI Stocks Are Beating the Market by 29 Points.

Which Healthcare ETF Offers the Better Growth Outlook: VanEck Biotech or Invesco Pharmaceuticals?

MASTERINVEST Kapitalanlage GmbH Makes New Investment in Amgen Inc. $AMGN - Markets Daily

North Star Asset Management Inc. Acquires New Shares in Amgen Inc. $AMGN

Valueworks LLC Takes Position in Amgen Inc. $AMGN

210,024 Shares in Amgen Inc. $AMGN Purchased by Public Employees Retirement System of Ohio - Stock Observer

Best Biotech Stocks To Research - August 28th - Daily Political

Empowered Funds LLC Takes Position in Amgen Inc. $AMGN

Equitable Holdings Inc. Buys Shares of 24,845 Amgen Inc. $AMGN

Centaurus Financial Inc. Acquires New Stake in Amgen Inc. $AMGN

Bank OZK Buys Shares of 11,793 Amgen Inc. $AMGN

AstraZeneca (LSE:AZN) Reports Positive TEZSPIRE Phase 3 Results, Is The Discount Too Wide?

'No longer proven to outweigh its risks': Ireland pulls medication linked to 20 deaths in Japan

Biotech Stocks To Watch Today - August 27th - Markets Daily

AZN/AMGN's Tezspire Hits Primary Goal in Eosinophilic Esophagitis Study

Amgen Inc. $AMGN Shares Sold by Strive Financial Group LLC - Markets Daily

Strive Financial Group LLC Cuts Position in Amgen Inc. $AMGN - Zolmax

Parvin Asset Management LLC Invests $2.04 Million in Amgen Inc. $AMGN

Global KIF18A Targeting Therapies Market Insights Report 2026: Profiles Volastra, Accent, Insilico, Amgen, Aurigene, Tailor Bio and Other Key Players

AstraZeneca, Amgen's Tezspire Meets Co-Primary, Key Secondary Endpoints In Phase 3 EoE Trial

9,297 Shares in Amgen Inc. $AMGN Acquired by Bontempo Ohly Capital Mgmt LLC - Stock Observer

Why Is Amgen (AMGN) Ending Its Crohn's Disease Research Partnership?

Med-tech companies face increasing attacks from cybercriminals

Amgen Inc. $AMGN Shares Acquired by Man Group plc

Primecap Management Co. CA Sells 2,117,167 Shares of Amgen Inc. $AMGN - Markets Daily

893,898 Shares in Amgen Inc. $AMGN Bought by Jupiter Topco LLC - Stock Observer

Primecap Management Co. CA Reduces Stake in Amgen Inc. $AMGN - Stock Observer

Canada Pension Plan Investment Board Boosts Stock Position in Amgen Inc. $AMGN - Daily Political

Biocon Secures Approval for Pegfilgrastim Biosimilar in Japan, Boosting Onco-supportive Therapy Options, ETPharma

Schwab SCHD draws $679M as dividend ETF climbs 2.39%

Legal & General Group Plc Sells 53,921 Shares of Amgen Inc. $AMGN

The Manufacturers Life Insurance Company Has $416.73 Million Stake in Amgen Inc. $AMGN

Evolve Private Wealth LLC Sells 3,508 Shares of Amgen Inc. $AMGN - Markets Daily

Amgen Inc. $AMGN Shares Acquired by Trajan Wealth LLC - Stock Observer

Amgen (NASDAQ:AMGN) Reaches New 1-Year High - Time to Buy?

Amgen (NASDAQ:AMGN) Hits New 12-Month High - Still a Buy? - Stock Observer

Biotech stocks are breaking out. How Josh Brown is trading them

Amgen Touches 52-Week High: Buy, Sell or Hold the Stock?

Beat the Market Like Zacks: Amgen, FirstCash, Delek in Focus

OMERS ADMINISTRATION Corp Reduces Position in Amgen Inc. $AMGN - Markets Daily

Ieq Capital LLC Decreases Stock Position in Amgen Inc. $AMGN

OMERS ADMINISTRATION Corp Trims Stock Position in Amgen Inc. $AMGN - Stock Observer

3 Market-Beating Stocks with Exciting Potential

Best Biotech Stocks To Watch Today - August 23rd - Daily Political

Elevation Point Wealth Partners LLC Acquires 4,062 Shares of Amgen Inc. $AMGN

Beutel Goodman & Co Ltd. Sells 128,742 Shares of Amgen Inc. $AMGN

Amgen Inc. $AMGN Shares Sold by Clear Harbor Asset Management LLC - Stock Observer

Amgen Inc. $AMGN Shares Sold by Commerce Bank - Daily Political

Korea Investment CORP Reduces Stake in Amgen Inc. $AMGN

Emerald Investment Advisers LLC Increases Stake in Amgen Inc. $AMGN

Amgen Inc. $AMGN Shares Bought by Emerald Investment Advisers LLC - Daily Political

Oncology Stocks: 8 Biggest NASDAQ Companies in 2026

FTC Challenges Amgen's Patent Play in Enbrel Antitrust Case | Morningstar

FTC Backs Antitrust Scrutiny of Amgen Over Enbrel Patent Deal

FTC Files Amicus Brief to Protect Competition in Biologic Drug Markets | Federal Trade Commission

Amgen (AMGN) Gets A Fresh Target, Is It Fully Priced?

Bank of New York Mellon Corp Sells 97,857 Shares of Amgen Inc. $AMGN

Amgen (NASDAQ:AMGN) Price Target Raised to $400.00

European regulators recall Amgen's rare disease drug Tavneos | BioWorld

Amgen Target of Unusually High Options Trading (NASDAQ:AMGN) - Stock Observer

Global DLL3 Targeted Therapies Market 2026-2030: Profiles Amgen, Zai Lab, Boehringer Ingelheim and Phanes Therapeutics

Multispecific Antibodies Market Report 2026: Forecast to Reach $60 Billion by 2031, Driven by Expanding Clinical Pipeline and Proprietary Technologies

2 Momentum Stocks Worth Investigating and 1 We Avoid

First National Bank of Omaha Has $15.65 Million Stake in Amgen Inc. $AMGN

Amgen Inc. $AMGN Shares Sold by Great Lakes Advisors LLC - Stock Observer

AMGN: IRS And Regulatory Setbacks Will Restrain Pipeline Driven Repricing

Moderna's cancer-vaccine breakthrough drives broad biopharma stock rally | Morningstar

Which Drugmaker Stock Has Dominated in 2026: Merck, Pfizer, or Amgen?

France recalls rare disease drug Tavneos after deaths

The Smartest Dividend ETF to Buy With $500 Right Now

Biotech Stocks To Keep An Eye On - August 19th - Daily Political

BlackRock Inc. Has $17.87 Billion Stock Holdings in Amgen Inc. $AMGN

Trust Co. of Vermont Takes Position in Amgen Inc. $AMGN - Stock Observer

Deutsche Bank AG Buys 99,946 Shares of Amgen Inc. $AMGN - Daily Political

Amgen (NASDAQ:AMGN) Reaches New 1-Year High on Analyst Upgrade

Amgen (NASDAQ:AMGN) Given New $352.00 Price Target at Mizuho

Amgen (NASDAQ:AMGN) Sets New 12-Month High After Analyst Upgrade - Stock Observer

Amgen Inc. $AMGN Stake Lessened by Wilkinson Global Asset Management LLC - Stock Observer

Amgen (NASDAQ:AMGN) Price Target Raised to $352.00 - Stock Observer

Kinsale Capital Group Inc. Raises Holdings in Amgen Inc. $AMGN - Stock Observer

Cantor Fitzgerald Forecasts Strong Price Appreciation for Amgen (NASDAQ:AMGN) Stock - Daily Political

KBC Group NV Buys 130,497 Shares of Amgen Inc. $AMGN - Zolmax

KBC Group NV Acquires 130,497 Shares of Amgen Inc. $AMGN

HighTower Advisors LLC Has $295.58 Million Holdings in Amgen Inc. $AMGN

Amgen Inc. $AMGN Stake Lowered by Janney Montgomery Scott LLC - Zolmax

HighTower Advisors LLC Has $295.58 Million Stake in Amgen Inc. $AMGN - Zolmax

111 Capital Has $1.40 Million Position in Amgen Inc. $AMGN

Mosaic Family Wealth Partners LLC Acquires 1,236 Shares of Amgen Inc. $AMGN - Stock Observer

Amgen price target raised to $380 from $360 at Barclays

Top Biotech Stocks To Watch Now - August 16th - Stock Observer

TD Asset Management Inc Grows Holdings in Amgen Inc. $AMGN - Zolmax

Amgen Inc. $AMGN Position Trimmed by Strive Financial Group LLC - Zolmax

US Economy on Stagflation Watch: Apollo Global Management's Outlook

AI Podcast: Fresh Insights on Fed Rate Cut Timing - News in a New Way

Stock Market Today: S&P 500 and Dow Reach New High On Trump’s Tariff Policy

The Week Ahead: ISM services, SMCI

Week ahead: RBA meeting, Uber earnings, and PMIs

Week ahead: Earnings season climax

Week ahead: Fed, Bank of England seen on pause; Apple earnings

Trump's Sudden Russia Policy Shift: Rubio's Influence and Implications

Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty

September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations

Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge

Fund Managers Cautious in Q4: AI, Inflation, and Monetary Policy in Focus

US Government Shutdown Threatens October Inflation Data Release

US-EU Relations: Russia Sanctions Unite Despite Trade Tensions

BOJ Warns of Japan Stock Market Overheating, U.S. Trade Policy Risk